{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:17:30Z","timestamp":1789129050672,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.forsciint.2022.111390","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T02:08:01Z","timestamp":1657678081000},"page":"111390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Screening suspect pharmaceuticals for illicit designer benzodiazepines using raman, SERS, and FT-IR prior to comprehensive analysis using LC-MS"],"prefix":"10.1016","volume":"338","author":[{"given":"Martin M.","family":"Kimani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skyler W.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Lanzarotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana L.","family":"Brueggemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JaCinta S.","family":"Batson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2022.111390_bib1","unstructured":"Charney D.S., Mihic S.J., Haris R.A. Chapter 16. Hypnotics and Sedatives. In: Brunton L.L., Lazo J.S., Parker K.L., eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11e. New York, NY: McGraw-Hill Medical Publishing."},{"issue":"1\u20132","key":"10.1016\/j.forsciint.2022.111390_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/02791072.1983.10472118","article-title":"The benzodiazepine story","volume":"15","author":"Sternbach","year":"1983","journal-title":"J. Psychoact. Drugs"},{"issue":"4","key":"10.1016\/j.forsciint.2022.111390_bib3","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.forsciint.2022.111390_bib4","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.forsciint.2022.111390_bib5","series-title":"LC-MS in Drug Analysis","first-page":"129","article-title":"The evolving landscape of designer drugs","author":"Kacinko","year":"2019"},{"key":"10.1016\/j.forsciint.2022.111390_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bpa.2018.06.007","article-title":"New benzodiazepines for sedation","volume":"32","author":"Cornett","year":"2018","journal-title":"Best. Pract. Res Clin. Anaesthesiol."},{"issue":"2","key":"10.1016\/j.forsciint.2022.111390_bib7","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated e\ufb00ects","volume":"13","author":"Gri\ufb03n 3rd","year":"2013","journal-title":"Ochsner J."},{"key":"10.1016\/j.forsciint.2022.111390_bib8","unstructured":"EMCDDA, 2018a. Perspective on Drugs. The Misuse of Benzodiazepines Among High-risk Opioid Users in Europe. Accessed May 7, 2020. http:\/\/www.emcdda.europa.eu\/topics\/pods\/benzodiazepines_en."},{"key":"10.1016\/j.forsciint.2022.111390_bib9","unstructured":"UNODC, 2017a. Non-medical Use of Benzodiazepines: a Growing Threat to Public Health? Global Smart Update. pp. 18. https:\/\/www.unodc.org\/documents\/scientific\/Global_SMART_Update_2017_Vol_18.pdf. https:\/\/www.drugabuse.gov\/drugs-abuse\/opioids\/benzodiazepines-opioids."},{"key":"10.1016\/j.forsciint.2022.111390_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11419-016-0338-5","article-title":"Metabolites replace the parent drug in the drug arena. The cases of fonazepam and nifoxipam","volume":"35","author":"Katselou","year":"2017","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2022.111390_bib11","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.15585\/mmwr.mm7034a2","article-title":"Trends in nonfatal and fatal overdoses involving benzodiazepines \u2014 38 States and the District of Columbia, 2019\u20132020","volume":"70","author":"Liu","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.forsciint.2022.111390_bib12","series-title":"New Psychoactive Substances","first-page":"383","article-title":"Designer benzodiazepines: another class of new psychoactive substances","author":"Moosmann","year":"2018"},{"key":"10.1016\/j.forsciint.2022.111390_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/dta.1628","article-title":"Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics","volume":"6","author":"Moosmann","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2022.111390_bib14","unstructured":"\u3008https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/734\/EMCDDA-Europol_\u30092012_Annual_Report_final_439477.pdf."},{"key":"10.1016\/j.forsciint.2022.111390_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/dta.2211","article-title":"The emergence of new psychoactive substance (NPS) benzodiazepines: a review","volume":"10","author":"Manchester","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2022.111390_bib16","unstructured":"NPR. Trump administration declares opioid crisis a public health emergency. \u3008https:\/\/www.npr.org\/2017\/10\/26\/560083795\/president-trump-may-declare-opioid-epidemic-national-emergency\u3009 (accessed February 17, 2020)."},{"key":"10.1016\/j.forsciint.2022.111390_bib17","unstructured":"H.R.6 \u2013 SUPPORT for Patients and Communities Act. https:\/\/www.con gress.gov\/bill\/115th-congress\/house-bill\/6 (accessed June 29, 2020)."},{"key":"10.1016\/j.forsciint.2022.111390_bib18","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/jms.3840","article-title":"Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines \u2014 an update comprising adinazolam, cloniprazepam, fonazepam, 3\u2013hydroxyphenazepam, metizolam and nitrazolam","volume":"51","author":"Moosmann","year":"2016","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.forsciint.2022.111390_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.forsciint.2016.09.006","article-title":"Blood concentrations of new designer benzodiazepines in forensic cases","volume":"268","author":"H\u00f8iseth","year":"2016","journal-title":"Forensic Sci. Int."},{"issue":"9","key":"10.1016\/j.forsciint.2022.111390_bib20","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/jat\/bkz063","article-title":"Validation of an LC-MS\/MS method for the quantification of 13 designer benzodiazepines in blood","volume":"43","author":"Mei","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2022.111390_bib21","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/dta.2003","article-title":"Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays","volume":"9","author":"Pettersson-Bergstrand","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2022.111390_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.forsciint.2017.01.027","article-title":"Identification of new psychoactive substances (NPS) using handheld Raman spectroscopy employing both 785 and 1064nm laser sources","volume":"273","author":"Guirguis","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2022.111390_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103611","article-title":"Rapid and accurate etizolam detection using surface-enhanced Raman spectroscopy for community drug checking","volume":"102","author":"Gozdzialski","year":"2022","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.forsciint.2022.111390_bib24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jpba.2017.09.005","article-title":"Development and implementation of a pass\/fail field-friendly method for detecting sildenafil in suspect pharmaceutical tablets using a handheld raman spectrometer and silver colloids","volume":"146","author":"Lanzarotta","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.forsciint.2022.111390_bib25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/1556-4029.14600","article-title":"Trace level detection of select opioids (fentanyl, hydrocodone, oxycodone and tramadol) in suspect pharmaceutical tablets using surface enhanced Raman scattering (SERS) with handheld devices","volume":"66","author":"Kimani","year":"2021","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2022.111390_bib26","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/1556-4029.14457","article-title":"Detection of Mitragynine in Mitragyna Speciosa (Kratom) using surface\u2010enhanced raman spectroscopy with handheld devices","volume":"65","author":"Lanzarotta","year":"2020","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2022.111390_bib27","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/1556-4029.14797","article-title":"Rapid determination of six benzodiazepines in suspected counterfeit pharmaceuticals using surface enhanced Raman Scattering (SERS) with handheld Raman spectrometers","volume":"66","author":"Kimani","year":"2021","journal-title":"J. Forensic Sci."},{"issue":"1","key":"10.1016\/j.forsciint.2022.111390_bib28","first-page":"52","article-title":"Detection of compounds found in an unapproved dermal filler using fourier transform infrared (FT-IR) and surface enhanced raman scattering (SERS) spectroscopy","volume":"25","author":"Kimani","year":"2022","journal-title":"Am. Pharm. Rev."},{"issue":"S9A","key":"10.1016\/j.forsciint.2022.111390_bib29","first-page":"17","article-title":"Analysis of unlabeled sibutramine in dietary supplements using surface-enhanced raman spectroscopy (SERS) with handheld devices","volume":"36","author":"Kimani","year":"2021","journal-title":"Spectroscopy"},{"issue":"1","key":"10.1016\/j.forsciint.2022.111390_bib30","first-page":"220","article-title":"The ANOR (Alternate Non-aqueous Organic Ratio) extraction procedure","volume":"XVI","author":"Adair","year":"1983","journal-title":"Microgram"},{"issue":"45","key":"10.1016\/j.forsciint.2022.111390_bib31","doi-asserted-by":"crossref","first-page":"29147","DOI":"10.1021\/acsomega.0c03878","article-title":"Recovery of active pharmaceutical ingredients from unused solid dosage-form drugs","volume":"5","author":"Pratama","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.forsciint.2022.111390_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0003-2670(00)84091-X","article-title":"Chemometric criteria for assessing the certainty of qualitative analytical methods","volume":"223","author":"De Ruig","year":"1989","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.forsciint.2022.111390_bib33","unstructured":"Erika, L.D. Development of a Surface-Enhanced Raman Spectroscopy Method for the Detection of Benzodiazepines in Urine (2014). FIU Electronic Theses and Dissertations. 1642. \u3008https:\/\/digitalcommons.fiu.edu\/etd\/1642\u3009."},{"issue":"3","key":"10.1016\/j.forsciint.2022.111390_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0924-2031(91)85006-9","article-title":"Fourier transform Raman and infrared study of nitrazepam, nimetazepam, clonazepam and flunitrazepam","volume":"1","author":"Neville","year":"1991","journal-title":"Vib. Spectrosc."},{"issue":"5","key":"10.1016\/j.forsciint.2022.111390_bib35","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jrs.1154","article-title":"Near-infrared Fourier transform surface-enhanced Raman scattering spectroscopy of 1,4-benzodiazepine drugs employing gold films over nanospheres","volume":"35","author":"Trachta","year":"2004","journal-title":"J. Raman Spectrosc."},{"issue":"1","key":"10.1016\/j.forsciint.2022.111390_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jrs.1250210104","article-title":"Fourier-transform Raman and infrared vibrational study of diazepam and 4 closely related 1,4-benzodiazpeines","volume":"21","author":"Neville","year":"1990","journal-title":"J. Raman Spectrosc."},{"key":"10.1016\/j.forsciint.2022.111390_bib37","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/jrs.1199","article-title":"Semi-quantitative analysis of alizarin and purpurin by surface enhanced resonance raman spectroscopy (SERRS) using silver colloids","volume":"35","author":"Shadi","year":"2004","journal-title":"J. Raman Spectrosc."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073822002201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073822002201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:09:14Z","timestamp":1759946954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073822002201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":37,"alternative-id":["S0379073822002201"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2022.111390","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening suspect pharmaceuticals for illicit designer benzodiazepines using raman, SERS, and FT-IR prior to comprehensive analysis using LC-MS","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2022.111390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111390"}}